Takeda Pharmaceutical Co., Ltd. (TAK)
20.24
-0.12
(-0.59%)
USD |
NYSE |
Oct 23, 16:00
20.24
0.00 (0.00%)
After-Hours: 20:00
Takeda Pharmaceutical Market Cap : 63.97B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 63.97B |
| October 22, 2026 | 64.35B |
| October 21, 2026 | 62.99B |
| October 20, 2026 | 63.46B |
| October 19, 2026 | 61.98B |
| October 16, 2026 | 62.17B |
| October 15, 2026 | 61.47B |
| October 14, 2026 | 60.08B |
| October 13, 2026 | 58.53B |
| October 12, 2026 | 59.04B |
| October 09, 2026 | 59.20B |
| October 08, 2026 | 58.53B |
| October 07, 2026 | 58.06B |
| October 06, 2026 | 57.21B |
| October 05, 2026 | 56.29B |
| October 02, 2026 | 56.45B |
| October 01, 2026 | 56.45B |
| September 30, 2026 | 57.49B |
| September 29, 2026 | 58.50B |
| September 28, 2026 | 59.74B |
| September 25, 2026 | 59.61B |
| September 24, 2026 | 58.76B |
| September 23, 2026 | 59.45B |
| September 22, 2026 | 59.89B |
| September 21, 2026 | 59.70B |
| Date | Value |
|---|---|
| September 18, 2026 | 59.77B |
| September 17, 2026 | 60.21B |
| September 16, 2026 | 58.91B |
| September 15, 2026 | 59.10B |
| September 14, 2026 | 58.79B |
| September 11, 2026 | 57.71B |
| September 10, 2026 | 57.24B |
| September 09, 2026 | 57.55B |
| September 08, 2026 | 57.90B |
| September 04, 2026 | 58.31B |
| September 03, 2026 | 59.13B |
| September 02, 2026 | 58.25B |
| September 01, 2026 | 57.62B |
| August 31, 2026 | 56.83B |
| August 28, 2026 | 56.99B |
| August 27, 2026 | 56.99B |
| August 26, 2026 | 57.62B |
| August 25, 2026 | 58.00B |
| August 24, 2026 | 57.65B |
| August 21, 2026 | 57.46B |
| August 20, 2026 | 57.30B |
| August 19, 2026 | 57.97B |
| August 18, 2026 | 57.05B |
| August 17, 2026 | 54.93B |
| August 14, 2026 | 55.72B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Sanofi | 101.01B |
| Dr. Reddy's Laboratories Ltd. | 11.00B |
| AstraZeneca PLC | 531.90B |
| Daiichi Sankyo Co., Ltd. | 32.48B |
| Eisai Co., Ltd. | 9.186B |
Market Cap Related Metrics
| PS Ratio | 2.154 |
| Price to Book Value | 1.376 |
| Price to Free Cash Flow | 23.99 |
| Price | 20.24 |
| Earnings Yield | -1.67% |
| Operating PE Ratio | 14.10 |